review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | M M Kura | |
Rajendra J Kothavade | |||
Arvind G Valand | |||
M H Panthaki | |||
P433 | issue | Pt 8 | |
P921 | main subject | Candida tropicalis | Q143138 |
P304 | page(s) | 873-880 | |
P577 | publication date | 2010-04-22 | |
P1433 | published in | Journal of Medical Microbiology | Q15708716 |
P1476 | title | Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole | |
P478 | volume | 59 |
Q41020292 | 1-n-Hexadecyl-3-methylimidazolium methanesulfonate and chloride salts with effective activities against Candida tropicalis biofilms. |
Q58805351 | A Prospective Study of Fungal Colonization and Invasive Fungal Disease in Long-Term Mechanically Ventilated Patients in a Respiratory Intensive Care Unit |
Q55006759 | A coupled process of same- and opposite-sex mating generates polyploidy and genetic diversity in Candida tropicalis. |
Q55439502 | Alterations in the gut bacterial microbiome in fungal Keratitis patients. |
Q33734709 | An Antifungal Mechanism of Protolichesterinic Acid from the Lichen Usnea albopunctata Lies in the Accumulation of Intracellular ROS and Mitochondria-Mediated Cell Death Due to Apoptosis in Candida tropicalis |
Q42682766 | An Update on Candida tropicalis Based on Basic and Clinical Approaches |
Q58585854 | An Update on the Roles of Non- Species in Vulvovaginitis |
Q37118510 | Analysis of the genetic diversity of Candida isolates obtained from diabetic patients and kidney transplant recipients. |
Q41228972 | Anti-Candida Activity of New Azole Derivatives Alone and in Combination with Fluconazole |
Q93007135 | Anti-Fungal Efficacy and Mechanisms of Flavonoids |
Q43821648 | Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species |
Q35166731 | Antifungal activity of naphthoquinoidal compounds in vitro against fluconazole-resistant strains of different Candida species: a special emphasis on mechanisms of action on Candida tropicalis. |
Q40118569 | Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region. |
Q37279005 | Antiproliferation of Berberine in Combination with Fluconazole from the Perspectives of Reactive Oxygen Species, Ergosterol and Drug Efflux in a Fluconazole-Resistant Candida tropicalis Isolate |
Q46293300 | Bacterial and fungal biodeterioration of discolored building paints in Lagos, Nigeria |
Q89551883 | Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies |
Q61799189 | CGA-N9, an antimicrobial peptide derived from chromogranin A: direct cell penetration of and endocytosis by |
Q34057053 | Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis |
Q92592097 | Candida Bloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital |
Q40424798 | Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms. |
Q38019018 | Candida species: new insights into biofilm formation. |
Q40318343 | Candida tropicalis Biofilms: Biomass, Metabolic Activity and Secreted Aspartyl Proteinase Production. |
Q37263791 | Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications. |
Q40988156 | Candida tropicalis as a Predominant Isolate from Clinical Specimens and its Antifungal Susceptibility Pattern in a Tertiary Care Hospital in Southern India |
Q41837719 | Candida tropicalis in a case of cholangiocarcinoma with cholangitis at a tertiary care hospital in Manipal |
Q46791655 | Candida tropicalis isolates obtained from veterinary sources show resistance to azoles and produce virulence factors |
Q34536205 | Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis |
Q38739328 | Characterization of the newly isolated ω-oxidizing yeast Candida sorbophila DS02 and its potential applications in long-chain dicarboxylic acid production. |
Q64898336 | Chemogenomic profiling in yeast reveals antifungal mode-of-action of polyene macrolactam auroramycin. |
Q46427960 | DS6: anticandidal, antibiofilm peptide against Candida tropicalis and exhibit synergy with commercial drug. |
Q42440128 | Determination of biofilm production by Candida tropicalis isolated from hospitalized patients and its relation to cellular surface hydrophobicity, plastic adherence and filamentation ability. |
Q57135855 | Development of Antibacterial and Antifungal Triazole Chromium(III) and Cobalt(II) Complexes: Synthesis and Biological Activity Evaluations |
Q57794715 | Diversity and relationships among strains of culturable yeasts in agricultural soils in Cameroon |
Q38708362 | Drug resistance mechanisms and their regulation in non-albicans Candida species |
Q51304948 | Effect of Voriconazole on Candida tropicalis Biofilms: Relation with ERG Genes Expression. |
Q59060511 | Effect of a Silver Nanoparticles Solution onStaphylococcus aureusandCandidaspp |
Q41062301 | Effects of human blood red cells on the haemolytic capability of clinical isolates of Candida tropicalis |
Q55100374 | Endovascular retrieval of a CardioMEMS heart failure system. |
Q46286037 | Environmental and genetic regulation of white-opaque switching in Candida tropicalis |
Q59058005 | Epidemiology and Virulence Determinants including Biofilm Profile of Candida Infections in an ICU in a Tertiary Hospital in India |
Q33851338 | Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India |
Q38711698 | Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus. |
Q35211480 | Evaluation of microbial load in oropharyngeal mucosa from tannery workers |
Q94563646 | Evaluation of nanomaterials to prevent oral Candidiasis in PMMA based denture wearing patients. A systematic analysis |
Q43312309 | Fungal succession in an in-vessel composting system characterized using 454 pyrosequencing |
Q39413843 | Fungicidal photodynamic effect of a twofold positively charged porphyrin against Candida albicans planktonic cells and biofilms |
Q64248239 | Genome-resolved metagenomics of eukaryotic populations during early colonization of premature infants and in hospital rooms |
Q58937194 | Green synthesis and antifungal activity of Al2O3 NPs against fluconazole-resistant Candida spp isolated from a tertiary care hospital |
Q47147760 | Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil. |
Q50000073 | Identification of fungi in shotgun metagenomics datasets |
Q33819809 | Identification of yeasts during alcoholic fermentation of tchapalo, a traditional sorghum beer from Côte d'Ivoire |
Q40034825 | In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species. |
Q64228908 | In Vitro Anti-Biofilm Activities of Citral and Thymol Against Candida Tropicalis |
Q38931003 | In Vitro Studies of Chromone-Tetrazoles against Pathogenic Protozoa, Bacteria, and Fungi. |
Q52616076 | In vitro differential activity of phospholipases and acid proteinases of clinical isolates of Candida. |
Q50053442 | In vitro effects of promethazine on cell morphology and structure and mitochondrial activity of azole-resistant Candida tropicalis. |
Q91992305 | In vitro interactions of crocin with fluconazole against Candida isolates |
Q35091118 | Influence of culture media on biofilm formation by Candida species and response of sessile cells to antifungals and oxidative stress. |
Q37950850 | Insights into Candida tropicalis nosocomial infections and virulence factors. |
Q36237993 | Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility. |
Q36556283 | Medical Device-Associated Candida Infections in a Rural Tertiary Care Teaching Hospital of India |
Q36969703 | Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals |
Q52309400 | Multilocus Sequence Typing Reveals a New Cluster of Closely Related Candida tropicalis Genotypes in Italian Patients With Neurological Disorders. |
Q37714473 | Notable Increasing Trend in Azole Non-susceptible Candida tropicalis Causing Invasive Candidiasis in China (August 2009 to July 2014): Molecular Epidemiology and Clinical Azole Consumption |
Q36184407 | Novel Polymorphic Multilocus Microsatellite Markers to Distinguish Candida tropicalis Isolates |
Q35750218 | Opportunistic Infections among People Living with HIV (PLHIV) with Diabetes Mellitus (DM) Attending a Tertiary Care Hospital in Coastal City of South India |
Q85937025 | Oxidative stress, glutathione level and antioxidant response to heavy metals in multi-resistant pathogen, Candida tropicalis |
Q95840950 | Palmitic Acid Inhibits the Virulence Factors of Candida tropicalis: Biofilms, Cell Surface Hydrophobicity, Ergosterol Biosynthesis, and Enzymatic Activity |
Q37469557 | Parasexuality and ploidy change in Candida tropicalis. |
Q46237270 | Protein kinase A governs growth and virulence in Candida tropicalis. |
Q85243022 | Pseudomembranous candidiasis in HIV/AIDS patients in Cali, Colombia |
Q47153623 | Radiation used for head and neck cancer increases virulence in Candida tropicalis isolated from a cancer patient |
Q36182009 | Rapid identification of yeast isolates from clinical specimens in critically ill trauma ICU patients |
Q92982138 | Rapidly progressive necrotizing cellulitis secondary to Candida tropicalis infection in an immunocompromised host |
Q35807206 | Regulation of filamentation in the human fungal pathogen Candida tropicalis |
Q35914510 | Repeat-Associated Fission Yeast-Like Regional Centromeres in the Ascomycetous Budding Yeast Candida tropicalis |
Q57579832 | Retrospective study on equine uterine fungal isolates and antifungal susceptibility patterns (1999-2011) |
Q92071612 | Role of Protein Mannosylation in the Candida tropicalis-Host Interaction |
Q35886365 | Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms |
Q61806421 | Sequential Photodynamic Therapy with Phthalocyanine Encapsulated Chitosan-Tripolyphosphate Nanoparticles and Flucytosine Treatment against |
Q41280455 | Silver oxynitrate, an unexplored silver compound with antimicrobial and antibiofilm activity |
Q36505494 | Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis. |
Q37643678 | Synergistic effect of the flavonoid catechin, quercetin, or epigallocatechin gallate with fluconazole induces apoptosis in Candida tropicalis resistant to fluconazole |
Q41756174 | Synthesis and anti-yeast evaluation of novel 2-alkylthio-4-chloro-5-methyl-N-[imino-(1-oxo-(1H)-phthalazin-2-yl)methyl]benzenesulfonamide derivatives. |
Q38009721 | The effect of biomaterials and antifungals on biofilm formation by Candida species: a review |
Q38077110 | Thriving within the host: Candida spp. interactions with phagocytic cells |
Q40474860 | Trehalose-6-Phosphate as a Potential Lead Candidate for the Development of Tps1 Inhibitors: Insights from the Trehalose Biosynthesis Pathway in Diverse Yeast Species. |
Q35752374 | Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification |
Q38920508 | Virulence Factors Contributing to Pathogenicity of Candida tropicalis and Its Antifungal Susceptibility Profile. |
Q57822571 | and antifungal activity of and |
Search more.